Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - Mechanism(s) of action in emergency contraception?

European Journal of Endocrinology

Volumn 152, Issue 3, 2005, Pages 411-418

  Leminen, Riikka ^a   Raivio, Taneli ^a   Ranta, Sirpa ^a   Oehler, Joachim ^b   von Hertzen, Helena ^c   Jänne, Olli A ^a   Heikinheimo, Oskari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b The Concept Foundation   (Thailand)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOCORTICOID; HYDROCORTISONE; LEPTIN; LUTEINIZING HORMONE; MIFEPRISTONE; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; EMERGENCY CONTRACEPTION; FEMALE; FOLLICULAR PHASE; FOLLITROPIN RELEASE; FOLLOW UP; HORMONE DETERMINATION; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; OVULATION INHIBITION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRANSVAGINAL ECHOGRAPHY; VOLUNTEER;

ADULT; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; LEPTIN; MENSTRUAL CYCLE; MIFEPRISTONE;

EID: 15944361850     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01884     Document Type: Article

References (39)

1. Glasier A, Thong KJ, Dewar M, Mackie M & Baird DT. Mifepristone (RU486) compared with high-dose estrogen, and progesterone for emergency postcoital contraception. New England Journal of Medicine 1992 327 1041-1044.
2. Webb AMC, Russell J & Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. British Medical Journal 1992 305 927-931.
3. WHO TaskForce on Postovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet 1999 353 697-702.
4. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Ludicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Kho-massurdze A, Axter D & Peregondov A. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002 360 1803-1810.
5. Croxatto HB, Devoto L, Durand M, Ezcurra E, Larrea F, Nagle C, Ortiz ME, Vantman D, Vega M & von Herzen H. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001 63 111-121.
6. Liu J, Garzo G, Morris S, Stunkel C, Ulmann A & Yen SS. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Journal of Clinical Endocrinology and Metabolism 1987 65 1135-1140.
7. Croxatto H, Salvatierra A, Fuentealba B & Leiva L. Follicle stimulating hormone-granulosa cell axis involvement in the antifolliculotrophic effect of low dose mifepristone (RU486). Human Reproduction 1995 10 1987-1991.
8. Marions L, Hultenby K, Lindell I, Sun X, Ståbi B & Gemzell-Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstetrics and Gynecology 2002 100 65-70.
9. Gemzell-Danielsson K, Mandl I & Marions L. Mechanisms of action of mifepristone when used for emergency contraception. Contraception 2003 68 471-476.
10. Hardie L, Trayhurn P, Abramovich D & Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clinical Endocrinology 1997 47 101-106.
11. Apter D. The role of leptin in female adolescence. Annals of the New York Academy of Sciences 2003 997 64-76.
12. Moschos S, Chan JL & Mantzoros CS. Leptin and reproduction: a review. Fertility and Sterility 2002 77 433-444.
13. Riad-Gabriel M, Jinagouda S, Sharma A, Boyadjian R & Saad M. Changes in plasma leptin during the menstrual cycle. European Journal of Endocrinology 1998 139 528-531.
14. Teirimaa T, Luukkaa V, Rouru J, Koulu M & Huupponen R. Correlation between circulating leptin and luteinizing hormone during the menstrual cycle in normal-weight women. European Journal of Endocrinology 1998 139 190-194.
15. Cella F, Giordano G & Cordera R. Serum leptin concentrations during the menstrual cycle in normal weight women: effects of an oral triphasic estrogen-progestin medication. European Journal of Endocrinology 2000 142 174-178.
16. Messinis IE, Papageorgiou I, Milingos S, Asprodini E, Kollios G & Seferiadis K. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Human Reproduction 2001 16 1827-1832.
17. Askari H, Liu J & Dagogo-Jack S. Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin. International Journal of Obesity 2000 24 1254-1259.
18. Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S & Nakao K. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 2543-2547.
19. Halleux CM, Saervais I, Reul BA, Detry R & Brichard SM. Multi-hormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. Journal of Clinical Endocrinology and Metabolism 1998 83 902-910.
20. Ottosson M, Marin P, Karason K, Elander A & Bjorntorp P. Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity. Obesity Research 1995 3 233-240.
21. Leminen R, Ranta S, von Hertzen H, Oehler J & Heikinheimo O. Pharmacokinetics of 10 mg of mifepristone. Contraception 2003 68 427-429.
22. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Programme for the Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology, Method Manual, edn 14, pp 50-60. Eds. SB Sufi A Donaldson SL Jeffcoate. London: WHO, 1990.
23. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H & Lähteenmäki P. Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography. Contraception 1986 34 613-623.
24. Raivio T, Palvimo JJ, Kannisto S, Voutilainen R & Jänne OA. Transactivation assay for determination of glucocorticoid bioactivity in human serum. Journal of Clinical Endocrinology and Metabolism 2002 87 3740-3744.
25. Matthews JN, Altman DG, Campbell MJ & Royston P. Analysis of serial measurements in medical research. British Medical Journal 1990 27 230-235.
26. Rowland M & Tozer TN. Concepts and Applications. In Clinical Pharmacokinetics, edn 2, pp 459. Philadelphia and London: Lea and Fabiger, 1984.
27. Xiao B, von Hertzen H, Zhao H & Piaggio G. A randomized double-blind comparison of two single doses of mifepristone for emergency contraception. Human Reproduction 2002 17 3084-3089.
28. Baird DT, Thong KJ, Hall C & Cameron ST. Failure of oestrogen-induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days. Human Reproduction 1995 10 2270-2276.
29. Collins R & Hodgen G. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU486: a progesterone antagonist or agonist. Journal of Clinical Endocrinology and Metabolism 1986 63 1270-1276.
30. Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Merriam GR & Loriaux DL. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. Journal of Clinical Endocrinology and Metabolism 1992 74 565-570.
31. Finn P, Cunningham M, Pau F, Spies H, Clifton D & Steiner R. The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 1998 139 4652-4662.
32. Watanobe H. Leptin directly acts within the hypothalamus to stimulate gonadotropin-releasing hormone secretion in vivo in rats. Journal of Physiology 2002 545 255-268.
33. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA & O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 1999 341 879-884.
34. Licinio J, Negrão A, Mantzoros C, Kaklamani V, Wong ML, Bongiorno P, Mulla A, Cearnal L, Veldhuis J, Flier J, McCann S & Gold F. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. PNAS 1998 95 2541-2546.
35. O'Brien SN, Welter BH, Mantzke KA & Price TM. Identification of progesterone receptor in human subcutaneous adipose tissue. Journal of Clinical Endocrinology and Metabolism 1998 83 509-513.
36. Casabiell X, Pineiro V, Peino R, Lage M, Camina J, Gallego R, Vallejo LG, Dieguez C & Casanueva FF. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. Journal of Clinical Endocrinology and Metabolism 1998 83 2149-2155.
37. Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP & Dagogo-Jack S. Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Archives of General Psychiatry 1998 55 995-1000.
38. Heikinheimo O, Haukkamaa M & Lähteenmäki P. Distribution of RU 486 and its demethylated metabolites in humans. Journal of Clinical Endocrinology and Metabolism 1989 68 270-275.
39. Vicennati V, Vottero A, Friedman C & Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. International Journal of Obesity 2002 26 905-911.